Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition
Bharadwaj, S. Deepika, K. Kumar, A. Jaiswal, S. Miglani, S. Singh, D. Fartyal, P. Kumar, R. Singh, S. Singh, M.P.
Bharadwaj, S.
Deepika, K.
Kumar, A.
Jaiswal, S.
Miglani, S.
Singh, D.
Fartyal, P.
Kumar, R.
Singh, S.
Singh, M.P.
Publication Date
2024-10-13
End of Embargo
Supervisor
Rights
© 2024 The Authors. Chemical Biology & Drug Design published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2024-09-24
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
The technological revolutions in computers and the advancement of high‐throughput screening technologies have driven the application of artificial intelligence (AI) for faster discovery of drug molecules with more efficiency, and cost‐friendly finding of hit or lead molecules. The ability of software and network frameworks to interpret molecular structures' representations and establish relationships/correlations has enabled various research teams to develop numerous AI platforms for identifying new lead molecules or discovering new targets for already established drug molecules. The prediction of biological activity, ADME properties, and toxicity parameters in early stages have reduced the chances of failure and associated costs in later clinical stages, which was observed at a high rate in the tedious, expensive, and laborious drug discovery process. This review focuses on the different AI and machine learning (ML) techniques with their applications mainly focused on the pharmaceutical industry. The applications of AI frameworks in the identification of molecular target, hit identification/hit‐to‐lead optimization, analyzing drug–receptor interactions, drug repurposing, polypharmacology, synthetic accessibility, clinical trial design, and pharmaceutical developments are discussed in detail. We have also compiled the details of various startups in AI in this field. This review will provide a comprehensive analysis and outline various state‐of‐the‐art AI/ML techniques to the readers with their framework applications. This review also highlights the challenges in this field, which need to be addressed for further success in pharmaceutical applications.
Version
Published version
Citation
Bharadwa S, Deepika K, Kumar A, et al (2024) Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition. Chemical Biology and Drug Design. 104(4): e14639.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article